Andreas Halvorsen Celldex Therapeutics Inc.

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$36.2

Avg closing price
Price range
Andreas Halvorsen Portfolio Stock Details (CLDX)

5 Andreas Halvorsen Celldex Therapeutics Trades

The first Celldex Therapeutics trade was made in Q3 2021. Since then Andreas Halvorsen bought shares two more times and sold shares on two occasions. The investor sold all their shares in Q3 2022 and doesn't own any shares in Celldex Therapeutics anymore.

Avg closing price
Price range
Sold -2.34 Million shares Q3 2022
Avg closing price $30.66
Price range $22.70 - $37.57
Increased shares by 26.6% (+491 Thousand shares) Q2 2022
Avg closing price $29.04
Price range $20.50 - $37.33
Increased shares by 143.7% (+1.09 Million shares) Q1 2022
Avg closing price $31.97
Price range $27.64 - $39.32
Sold 0.6% shares (-4.42 Thousand shares) Q4 2021
Avg closing price $43.58
Price range $35.68 - $56.27
New holding (+762 Thousand shares) Q3 2021
Avg closing price $46.92
Price range $28.95 - $55.99
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!

To improve your user experience we use cookies.